Surrogacy Market Size & Share 2025 – 2034

Surrogacy Market Size

The global surrogacy market was estimated at USD 22.4 billion in 2024. The market is expected to grow from USD 27.9 billion in 2025 to USD 201.8 billion in 2034, at a CAGR of 24.6% during the forecast period. Surrogacy refers to the technologies and services that support intended parents, couples or individuals seeking to have a child through a surrogate. This market includes fertility clinics, hospitals, and healthcare professionals involved in assisted reproductive procedures.

The growth of the market is largely influenced by the rising rate of infertility among individuals and couples globally. Infertility is a complex medical concern that is affecting a larger pool of individuals globally. For instance, according to the 2025 study published in the Journal of Human reproduction, in 2021, around 55,000,818 men and 110,089,459 women globally were living with infertility, equating to 1,820.6 cases of males and 3,713.2 cases of female per 100,000 population.
 

Moreover, as per the data from the World Health Organization (WHO), 17.5% of the adult population across the world experiences infertility in their lifetime, which is equivalent to 1 in 6 individuals. Therefore, as the prevalence of infertility increase among the individual and couples so does the need for assisted reproductive technology (ART), which is estimated to reach USD 62.8 billion by 2032,  and surrogacy services, thereby propelling the market growth.
 

Additionally, the rising awareness pertaining to the available treatment of fertility, including surrogacy is on rise, due to the educational campaigns, technological advancement in the methodology of ART, as well as the increasing accessibility of the fertility clinics among the individuals and couples. For instance, organizations such as American Society for Reproductive Medicine (ASRM) and Resolve: The National Infertility Association, undertake many educational campaigns to the educate the individuals regarding the surrogacy options, process, legal aspects pertaining to the surrogacy, as well as implication to the intended surrogates and the parents alike. Thus, the increasing awareness through such educational campaigns stimulating the individual to make more informed decision regarding the fertility treatment options, fuelling the adoption rate of surrogacy as a crucial option for family planning.
 

Surrogacy Market Trends

• The increasing number of fertility clinics across the world makes the surrogacy service more accessible among individuals.  For instance, as per the article published in The Economic Times, India has over 2,500 fertility clinics across the nation. These fertility clinics are equipped with advanced medical infrastructure, reproductive technologies, and highly skilled medical professionals to give the utmost care and treatment options to the individuals and couples seeking fertility treatment, including surrogacy as a family planning option.
   
• Moreover, the increasing adoption of the unhealthy lifestyle such as stress, lack of physical activity, smoking, and poor dietary intake among the individuals across the globe is a key catalyst of hormonal imbalances and declining rate of reproductive health among the individuals, thereby rising adoption of ART services among them, accelerating the market growth.
   
• According to the study in Reproductive Biology and Endocrinology, approximately 10 to 15% of couples across the globe are affected by infertility. Moreover, it was estimated that around 7.4% of women and their husbands in the U.S. are impacted by infertility, with the lifestyle factor was one of the key reasons for infertility among them.
   
• Therefore, as these trends continue to rise, so does the need for assisted reproductive services such as surrogacy, boosting market growth.  
   

Trump Administration Tariffs

• The Trump administrations tariffs on imports from China which include medical devices, electronic components, and pharmaceutical intermediates could increase cost structures for the surrogacy service providers. Fertility clinics and agencies that depend on low-cost medical supplies from China, such as ultrasound equipment, hormone assay instruments, and embryo transfer devices, may find these tariffs difficult.
   
• Tackling these challenges may force firms operating in the surrogacy market to reconsider their sourcing and production policies to reduce dependence on Chinese supply chains. This might prompt a shift to other sourcing countries with lower tariffs, such as India, Malaysia, and Eastern Europe, which also have similar manufacturing capabilities.
   
• Immediate effects may include the more rigorously controlled access to vital medical equipment, higher operational costs related to supplier diversification, and possible service delivery disruptions stemming from interrupted technical support and spare parts availability for critical monitoring and diagnostic systems.
   

Surrogacy Market Analysis

Based on type, the market is divided into gestational surrogacy and traditional surrogacy. The global market was estimated at USD 18 billion in 2023. The gestational surrogacy segment held revenues of USD 21.4 billion in the year 2024 and the segment is poised for significant growth at a CAGR of 24.9% during the forecast period.
 

• The growth of the segment is highly attributed due to the regulatory acceptances and favourable regulations of gestational surrogacy in many countries. Developed countries such as U.S. have a well-regulated and structured regulation in many states of the nation, making gestational surrogacy more accessible as compared to traditional surrogacy among the individuals.
   
• For instance, in New York, The Child-Parent Security Act (CPSA), effective from February 2021, legalized gestational surrogacy and introduced a rule stating that the surrogacy organization of the state should possess proper licences that should comply with the state regulations.
   
• Moreover, the act also consists of Surrogates Bill of Rights, which ensures the surrogate have a full control over their health condition, necessary insurance coverage during the period of pregnancy, and as well as protect the surrogate from unfair surrogacy contract.
   
• Therefore, these regulatory frameworks boost the adoption of gestational surrogacy among the couples seeking for planning a family, propelling the segmental growth.
   

Based on technology, the surrogacy market is bifurcated into intrauterine insemination (IUI), in-vitro fertilization (IVF), and other technologies. The in-vitro fertilization segment is further bifurcated into classical/standard IVF and intracytoplasmic sperm injection (ICSI). The in-vitro fertilization (IVF) segment held a market share of 63.4% in 2024 and the market is predicted to grow at 24.7% CAGR during the forecast period.
 

• The rising prevalence of the infertility due to lifestyle factors, medical condition, and delayed pregnancy is a major catalyst for the growth of the segment.
   
• For instance, as per the data from the Indian Journal of Community Medicine, around 60 to 80 million couples suffer from infertility annually worldwide, among them 15 to 20 million couples resides in India, equivalent to 25% of the total infertility population.
   
• Therefore, as the rate of infertility rise among the population so does the need for effective treatment and family planning option for the individuals seeking a child, thereby boosting the demand for IVF based surrogacy.
   
• Moreover, the increasing acceptance of the same sex parenting in the many countries of the world stimulating the demand for the IVF based surrogacy, since this technology support biological parenting even in the complex fertility situation, thereby stimulating the growth of the segment.
   

Based on age group, the surrogacy market is bifurcated into below 35 years, 35-37 years, 38 - 39 years, 40-42 years, 43-44 years, and over 44 years. The below 35 years segment is growing robustly, with a 25.1% CAGR during the forecast period.
 

• The growth of the segment is owing to the better egg quality and the ovarian reserve possessed by the women of the age group below 35, leading to high rate of success in IVF based surrogacy.
   
• For instance, as per the data from the American College of Obstetricians and Gynecologists (ACOG), the rate of fertility prominently starts to decline at the age of early 30s and 35. Thus, the surrogate of age group of below 35 years is an ideal choice among the couples intending to become parents and for fertility clinics offering the surrogacy services.  
   
• Moreover, the rising regulatory framework and structured law for surrogacy across the world, making younger women easier to participate in the surrogacy programs, thereby propelling the segment growth.
   

Based on end use, the surrogacy market is bifurcated into under hospitals, fertility clinics, and other end users. The fertility clinics segment accounted for a share of 63.3% in 2024.
 

• Fertility clinics act as a one stop destination for individuals seeking fertility treatment such as IVF, egg and sperm freezing, embryo banking and transferring, making them an ideal choice for couples intending to be parents through surrogacy. Their advanced medical technology ensures a high success rate compared to other healthcare facilities.
   
• These clinics provide end to end surrogacy services, inclusive of screening, fertility treatment, psychological and legal consultations, and matching a surrogate for intended parent, thus, these services streamline the surrogacy process, propelling the market share of these clinics, in the fast-pacing market of surrogacy.
   
• Moreover, fertility clinics often collaborate with research institutions to adopt advanced technologies pertaining to the IVF and cryopreservation technologies in order to expand their competitive edge in the market.
   

North America: In 2024, the U.S. led the North America surrogacy market, generated a revenue of USD 5.1 billion. The U.S. market was valued at USD 4 billion in 2023.
 

• The increasing prevalence of infertility among couples and individuals is the key catalyst for the growth of the market in the country.
   
• According to the recent data from the U.S. Centers for Disease Control and Prevention, around 13.4% of the women of age group 15 - 49 suffer from impaired fertility. Moreover, around 8.5% of married women of this age suffer from infertility in the U.S.
   
• Therefore, as the rate of infertility increases, so does the need for various fertility options among the couples intending to have a baby, further fostering the growth and adoption of IVF based surrogacy among the infertile couples in the country, thereby propelling the market growth in the country.
   

Europe: The surrogacy market in the UK is projected to grow significantly from 2025 to 2034.
 

• The growth of the market in the country is largely attributed due to rising awareness and social acceptance of surrogacy in the country.
   
• According to the data from the Human Fertilization and Embryology Authority, in 2022 approximately 0.4% of the IVF treatment cycle in UK were intended for surrogacy, with the number of surrogates increased from 130 in 2012 to 230 in 2022.
   
• Thus, the increasing acceptance of surrogacy, boosting the growth of the market in the country.
   

Asia Pacific: The surrogacy market in the India is projected to grow significantly from 2025 to 2034.
 

• The strong regulatory framework of the country increases the traction among the infertile couples to explore the option of becoming parents through surrogacy.
   
• Under the Surrogacy Act 2021, the woman of the age group 35-45 years, whether she can be a widow, divorcee, or a couple, defined as legally married woman and man, can avail the surrogacy in the country if the individual is suffering from any medical condition.
   
• Thus, such supportive regulations propel the adoption of surrogacy in the country, boosting the market.
   

Africa: The surrogacy market in the South Africa is projected to grow significantly from 2025 to 2034.
 

• The rising technological advancement in ART specifically IVF increasing the success rate and accessibility of these procedure, making surrogacy a more viable option in the developing countries such as South Africa.
   
• Therefore, as the country starts to adopt advanced technological procedures for surrogacy, the market is anticipated to grow rapidly in the country in the coming years.
   

Surrogacy Market Share

The top 4 players of the market account for approximately 15% of the market share which includes companies such as Boston IVF, New Hope Fertility Clinic, Bourn Hall International, Houston Fertility Center, among others. Moreover, strategic partnerships with fertility clinics, hospitals, healthcare providers, research institutes, and government agencies play a key role in advancing the development of surrogacy technologies. Moreover, the development of public awareness through the campaigns, social media platform is playing a crucial role in educating the individual regarding the surrogacy, boosting the adoption, and expanding the market reach, enabling market players to strengthen their position in this growing sector.
 

Surrogacy Market Companies

Some of the eminent market participants operating in the surrogacy industry include:

• IVIRMA
• Bangkok IVF Center
• Boston IVF
• Bourn Hall International (TVM Capital Healthcare)
• Circle Surrogacy
• Extraordinary Conceptions
• Growing Generations
• Houston Fertility Center
• Kindbody
• Max Healthcare
• MLSPL (Morpheus IVF Clinic)
• New Hope Fertility Clinic
• NOVA IVF
• Ovation Fertility
• Scanfert Clinic
   
• Boston IVF is one of the largest providers of IVF in the U.S., with over nine centers, 30 offices and 31 physicians across ten states.
   
• Houston Fertility Center offers a wide range of advanced reproductive services, including in vitro fertilization (IVF), fertility preservation, and innovative INVOcell treatment. This comprehensive service ensures that patients have access to multiple options tailored to their specific needs.
   

Surrogacy Industry News:

• In November 2023, Spanish investment firm GED Capital and fertility group IVIRMA Global acquired the Barcelona-based fertility business Eugin Group in a deal valued at up to EUR 500 million (USD 558.4 million), including earn-outs. This acquisition enabled IVIRMA Global to further its expansion into the North America market.
   
• In August 2022, Kindbody announced the acquisition of Chicago-based Alternative Reproductive Resources (ARR), a prominent gestational surrogacy agency. This acquisition integrated gestational surrogacy services in-house, ensuring a seamless continuum of patient care. As part of the expansion, the ARR team joined Kindbody’s KindEOS division, the company’s in-house egg and embryo donor program, to better serve Kindbody patients.
   

The surrogacy market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Gestational surrogacy
• Traditional surrogacy                   

Market, By Technology

• Intrauterine insemination (IUI)
• In-vitro fertilization (IVF)
  • Classical/standard IVF
  • Intracytoplasmic sperm injection (ICSI)
• Other technologies

Market, By Age Group

• Below 35 years
• 35-37 years
• 38 - 39 years
• 40-42 years
• 43-44 years
• Over 44 years

Market, By Service Provider

• Hospitals
• Fertility clinics
• Other service providers                

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Czech Republic
  • Estonia
  • Georgia
  • Greece
  • Poland
  • Sweden
  • UK
• Asia Pacific 
  • India
  • Thailand
  • South Korea
  • Australia
• Africa 
  • Kenya
  • Nigeria
  • South Africa